Given the demonstrated ability of the IM to promote an insulin-resistant state, and the long-term metabolic complications causing significant morbidity in SOT recipients, we wished to assess whether immunosuppressants led to changes in the IM and whether these changes could be correlated with hyperglycemia. Here, INS is linked to Hyperglycemia.